{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:47:15Z","timestamp":1790214435725,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["API01662FW"],"award-info":[{"award-number":["API01662FW"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["Momentum Program LP2012-025"],"award-info":[{"award-number":["Momentum Program LP2012-025"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2017.00095","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T03:59:48Z","timestamp":1495598388000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca2+ Pump PMCA4b and Inhibits the Migration of Melanoma Cells Independent of ERK"],"prefix":"10.3389","volume":"7","author":[{"given":"Luca","family":"Heged\u00fcs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pad\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"P\u00e1szty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Kenessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"S\u00e1rk\u00f6zy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Homolya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Heged\u00fcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"T\u00edm\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u00f6","family":"K\u00e1llay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Enyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"851387","DOI":"10.1155\/2015\/851387","article-title":"Novel approaches to treatment of advanced melanoma: a review on targeted therapy and immunotherapy","volume":"2015","author":"Niezgoda","year":"2015","journal-title":"Biomed Res Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11864-015-0330-z","article-title":"Treatment of NRAS-mutant melanoma","volume":"16","author":"Johnson","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejcsup.2013.07.011","article-title":"Targeted therapy in melanoma \u2013 the role of BRAF, RAS and KIT mutations","volume":"11","author":"Goldinger","year":"2013","journal-title":"EJC Suppl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Sullivan","year":"2013","journal-title":"Eur J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ejso.2016.07.145","article-title":"Immunotherapy in melanoma: recent advances and future directions","volume":"43","author":"Franklin","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"B8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ceca.2013.12.003","article-title":"Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells","volume":"55","author":"Varga","year":"2014","journal-title":"Cell Calcium"},{"key":"B10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ceca.2007.02.003","article-title":"Isoform-specific up-regulation of plasma membrane Ca2+ATPase expression during colon and gastric cancer cell differentiation","volume":"42","author":"Ribiczey","year":"2007","journal-title":"Cell Calcium"},{"key":"B11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2407-9-395","article-title":"High class I HDAC activity and expression are associated with RelA\/p65 activation in pancreatic cancer in vitro and in vivo","volume":"9","author":"Lehmann","year":"2009","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00280-013-2223-9","article-title":"Histones and lung cancer: are the histone deacetylases a promising therapeutic target?","volume":"72","author":"Petta","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-397927-8.00002-6","article-title":"Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors","volume":"65","author":"Lai","year":"2012","journal-title":"Adv Pharmacol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1535-7163.425.3.4","article-title":"The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells","volume":"3","author":"Zhang","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1023\/B:APPT.0000038036.31271.50","article-title":"Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors","volume":"9","author":"Facchetti","year":"2004","journal-title":"Apoptosis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/CMR.0b013e328364c0ed","article-title":"The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity","volume":"23","author":"Woods","year":"2013","journal-title":"Melanoma Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/exd.13089","article-title":"Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside","volume":"25","author":"Hornig","year":"2016","journal-title":"Exp Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.bbamcr.2015.12.011","article-title":"Multifaceted plasma membrane Ca(2+) pumps: from structure to intracellular Ca(2+) handling and cancer","volume":"1863","author":"Padanyi","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/07357907.2012.657817","article-title":"Plasma membrane calcium ATPase expression in human colon multistep carcinogenesis","volume":"30","author":"Ruschoff","year":"2012","journal-title":"Cancer Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1002\/ijc.30503","article-title":"The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells","volume":"140","author":"Hegedus","year":"2016","journal-title":"Int J Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1600-0625.2012.01565.x","article-title":"Role of TRPM in melanocytes and melanoma","volume":"21","author":"Guo","year":"2012","journal-title":"Exp Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pcmr.12222","article-title":"Inverse regulation of melanoma growth and migration by Orai1\/STIM2-dependent calcium entry","volume":"27","author":"Stanisz","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e89292","DOI":"10.1371\/journal.pone.0089292","article-title":"Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration","volume":"9","author":"Umemura","year":"2014","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1083\/jcb.201407082","article-title":"STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion","volume":"207","author":"Sun","year":"2014","journal-title":"J Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/bj3160353","article-title":"Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies","volume":"316","author":"Caride","year":"1996","journal-title":"Biochem J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23741","DOI":"10.1074\/jbc.272.38.23741","article-title":"Plasma membrane Ca2+ pump in rat brain. Patterns of alternative splices seen by isoform-specific antibodies","volume":"272","author":"Filoteo","year":"1997","journal-title":"J Biol Chem"},{"key":"B28","first-page":"3239","article-title":"A rapid in vitro assay for quantitating the invasive potential of tumor cells","volume":"47","author":"Albini","year":"1987","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/j.bbamcr.2013.06.021","article-title":"A C-terminal di-leucine motif controls plasma membrane expression of PMCA4b","volume":"1833","author":"Antalffy","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1755-148X.2010.00685.x","article-title":"PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells","volume":"23","author":"Halaban","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","article-title":"Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance","volume":"76","author":"Krumm","year":"2016","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0002-9440(10)62968-9","article-title":"The loss of sarco\/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis","volume":"167","author":"Brouland","year":"2005","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1111\/febs.12064","article-title":"Modulation of endoplasmic reticulum calcium pump expression during lung cancer cell differentiation","volume":"280","author":"Arbabian","year":"2013","journal-title":"FEBS J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12757","article-title":"Histone deacetylases function as novel potential therapeutic targets for cancer","author":"Zhang","year":"2016","journal-title":"Hepatol Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.bbrc.2007.02.050","article-title":"Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation","volume":"355","author":"Aung","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1152\/physrev.00012.2010","article-title":"Epigenetic regulation of gene expression in physiological and pathological brain processes","volume":"91","author":"Graff","year":"2011","journal-title":"Physiol Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"ra19","DOI":"10.1126\/scisignal.2005672","article-title":"Plasma membrane Ca(2)(+)-ATPases can shape the pattern of Ca(2)(+) transients induced by store-operated Ca(2)(+) entry","volume":"8","author":"Paszty","year":"2015","journal-title":"Sci Signal"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/ATVBAHA.114.304363","article-title":"Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin","volume":"34","author":"Baggott","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ncb2906","article-title":"A polarized Ca2+, diacylglycerol and STIM1 signalling system regulates directed cell migration","volume":"16","author":"Tsai","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ceca.2010.10.001","article-title":"Transcriptional mechanisms regulating Ca(2+) homeostasis","volume":"49","author":"Ritchie","year":"2011","journal-title":"Cell Calcium"},{"key":"B41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbrc.2015.06.113","article-title":"Selective upregulation of the expression of plasma membrane calcium ATPase isoforms upon differentiation and 1,25(OH)2D3-vitamin treatment of colon cancer cells","volume":"464","author":"Ribiczey","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2015.09.087","article-title":"Deletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1,25-dihydroxyvitamin D3","volume":"467","author":"Ryan","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1200\/JCO.2015.64.1357","article-title":"Association of vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein","volume":"34","author":"Fang","year":"2016","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"40370","DOI":"10.1038\/srep40370","article-title":"Antiproliferative effects of 1alpha-OH-vitD3 in malignant melanoma: potential therapeutic implications","volume":"7","author":"Spath","year":"2017","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1038\/emm.2016.69","article-title":"Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells","volume":"48","author":"Hong","year":"2016","journal-title":"Exp Mol Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/ars.2011.4022","article-title":"Redox regulation of SERCA2 is required for vascular endothelial growth factor-induced signaling and endothelial cell migration","volume":"17","author":"Evangelista","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12885-016-2693-3","article-title":"Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity","volume":"16","author":"Diaz-Nunez","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2017.00095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T20:50:57Z","timestamp":1659041457000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2017.00095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":47,"alternative-id":["10.3389\/fonc.2017.00095"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2017.00095","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,24]]},"article-number":"95"}}